Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162707 · ClinicalTrials.gov registry record · NA
Wireless, Intermittent Monitoring of Right Heart Pressures in HF
A NA study of NYHA Class III Heart Failure, sponsored by CardioMEMS.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 4
- Study locations
NCT01162707: Completed NA study of NYHA Class III Heart Failure, sponsored by CardioMEMS.
NCT01162707 is a NA study of NYHA Class III Heart Failure that has completed, run by CardioMEMS. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01162707, a NA study of NYHA Class III Heart Failure, has completed, sponsored by CardioMEMS.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the trial is to evaluate the wireless monitoring of pulmonary artery pressure using the CardioMEMS HF Pressure Measurement System in adult subjects with NYHA Class III Heart Failure.
Primary Outcome
The trial will demonstrate that the CardioMEMS Sensor can be positioned in the right or left pulmonary artery, and the Sensor pulmonary artery pressure measurements correlate to standardized methods of intra-cardiac pressure measurements immediately after deployment of the sensor and at the 60 day follow-up visit. Safety is assessed by monitoring the occurrence of adverse events.
Conditions Studied
Interventions
- DEVICE CardioMEMS HF Pressure Measurement System
Study Locations (4)
Georgia
- Piedmont Hospital - Atlanta
Ohio
- Ohio State University Hospital - Columbus
Oklahoma
- Oklahoma Heart Hospital - Oklahoma City
Tennessee
- St Thomas Hospital - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01162707 record still lists
NCT01162707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with NYHA Class III Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS HF Pressure Measurement System is the first listed.
NCT01162707 reports a single indexed study location in Georgia, Ohio, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01162707 about?
NCT01162707 is a clinical study titled "Wireless, Intermittent Monitoring of Right Heart Pressures in HF". The purpose of the trial is to evaluate the wireless monitoring of pulmonary artery pressure using the CardioMEMS HF Pressure Measurement System in adult subjects with NYHA Class III Heart Failure.
What is the current status of trial NCT01162707?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2006-12. Estimated completion is 2012-09.
What conditions does trial NCT01162707 study?
This clinical trial studies the following conditions: NYHA Class III Heart Failure.
What interventions are being tested in trial NCT01162707?
The interventions under investigation include: CardioMEMS HF Pressure Measurement System (DEVICE).
Who is sponsoring clinical trial NCT01162707?
This trial is sponsored by CardioMEMS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01162707 being conducted?
This trial has 4 study locations across Georgia, Ohio, Oklahoma, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NYHA Class III Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01162707's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia